Emerging evidence has revealed that PLAGL2 acts as an oncogene in various cancers, such as neuroblastoma, non‐small cell lung cancer, prostate cancer, colorectal cancer, and leukemia.27, 28, 29, 30. The gene discussed is PLAGL2; the disease is prostate cancer.